As of February 2026 Arbutus Biopharma has a market cap of NZ$1.21 Billion. This makes Arbutus Biopharma the world's 6549th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 4th, 2026 the market cap of Arbutus Biopharma was reported to be: